Lenalidomide and Dexamethasone in Primary Plasma Cell Leukemia
Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
This is an open label, multicenter, exploratory, single arm, two-stage study aiming to
explore efficacy and safety of lenalidomide and dexamethasone combination (LD) as first line
therapy in previously untreated patients with primary Plasma Cell leukemia (PPCL).
Phase:
Phase 2
Details
Lead Sponsor:
IRCCS Centro di Riferimento Oncologico della Basilicata